Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Protein-engineered hydrogels enhance the survival of induced pluripotent stem cell-derived endothelial cells for treatment of peripheral arterial disease.

Foster AA, Dewi RE, Cai L, Hou L, Strassberg Z, Alcazar CA, Heilshorn SC, Huang NF.

Biomater Sci. 2018 Feb 27;6(3):614-622. doi: 10.1039/c7bm00883j.

PMID:
29406542
2.

Maintenance of neural progenitor cell stemness in 3D hydrogels requires matrix remodelling.

Madl CM, LeSavage BL, Dewi RE, Dinh CB, Stowers RS, Khariton M, Lampe KJ, Nguyen D, Chaudhuri O, Enejder A, Heilshorn SC.

Nat Mater. 2017 Dec;16(12):1233-1242. doi: 10.1038/nmat5020. Epub 2017 Oct 30.

3.

Improvement of paracellular transport in the Caco-2 drug screening model using protein-engineered substrates.

DiMarco RL, Hunt DR, Dewi RE, Heilshorn SC.

Biomaterials. 2017 Jun;129:152-162. doi: 10.1016/j.biomaterials.2017.03.023. Epub 2017 Mar 18.

PMID:
28342321
4.

YAP-dependent mechanotransduction is required for proliferation and migration on native-like substrate topography.

Mascharak S, Benitez PL, Proctor AC, Madl CM, Hu KH, Dewi RE, Butte MJ, Heilshorn SC.

Biomaterials. 2017 Jan;115:155-166. doi: 10.1016/j.biomaterials.2016.11.019. Epub 2016 Nov 16.

5.

Regulating Stem Cell Secretome Using Injectable Hydrogels with In Situ Network Formation.

Cai L, Dewi RE, Goldstone AB, Cohen JE, Steele AN, Woo YJ, Heilshorn SC.

Adv Healthc Mater. 2016 Nov;5(21):2758-2764. doi: 10.1002/adhm.201600497. Epub 2016 Oct 6.

6.

Protein-engineered scaffolds for in vitro 3D culture of primary adult intestinal organoids.

DiMarco RL, Dewi RE, Bernal G, Kuo C, Heilshorn SC.

Biomater Sci. 2015 Oct 15;3(10):1376-85. doi: 10.1039/c5bm00108k. Epub 2015 Jul 16.

PMID:
26371971
7.

Injectable Hydrogels with In Situ Double Network Formation Enhance Retention of Transplanted Stem Cells.

Cai L, Dewi RE, Heilshorn SC.

Adv Funct Mater. 2015 Mar 4;25(9):1344-1351. No abstract available.

8.

Microfluidic analysis of extracellular matrix-bFGF crosstalk on primary human myoblast chemoproliferation, chemokinesis, and chemotaxis.

Ferreira MM, Dewi RE, Heilshorn SC.

Integr Biol (Camb). 2015 May;7(5):569-79. doi: 10.1039/c5ib00060b. Epub 2015 Apr 24.

9.

Avidity-controlled hydrogels for injectable co-delivery of induced pluripotent stem cell-derived endothelial cells and growth factors.

Mulyasasmita W, Cai L, Dewi RE, Jha A, Ullmann SD, Luong RH, Huang NF, Heilshorn SC.

J Control Release. 2014 Oct 10;191:71-81. doi: 10.1016/j.jconrel.2014.05.015. Epub 2014 May 18.

10.

Chemotaxis of human induced pluripotent stem cell-derived endothelial cells.

Huang NF, Dewi RE, Okogbaa J, Lee JC, Jalilrufaihah A, Heilshorn SC, Cooke JP.

Am J Transl Res. 2013 Aug 15;5(5):510-20. eCollection 2013.

11.

Metformin prevents liver tumorigenesis by inhibiting pathways driving hepatic lipogenesis.

Bhalla K, Hwang BJ, Dewi RE, Twaddel W, Goloubeva OG, Wong KK, Saxena NK, Biswal S, Girnun GD.

Cancer Prev Res (Phila). 2012 Apr;5(4):544-52. doi: 10.1158/1940-6207.CAPR-11-0228. Epub 2012 Mar 31.

12.

PGC1α promotes tumor growth by inducing gene expression programs supporting lipogenesis.

Bhalla K, Hwang BJ, Dewi RE, Ou L, Twaddel W, Fang HB, Vafai SB, Vazquez F, Puigserver P, Boros L, Girnun GD.

Cancer Res. 2011 Nov 1;71(21):6888-98. doi: 10.1158/0008-5472.CAN-11-1011. Epub 2011 Sep 13.

Supplemental Content

Support Center